News and features

A single letter in a strand of DNA within tumours is linked to longer survival times for some patients treated for bowel cancer, a new study reveals.

A new fundraising appeal by The Institute of Cancer Research, London, for research using a new type of high-tech microscope has raised an amazing £50,000.

The Institute of Cancer Research, London, has issued a statement in response to the decision by NICE to approve the use of radium-223 for treating hormone-relapsed prostate cancer with bone metastases if docetaxel chemotherapy isn’t a suitable treatment option.

A blood test that detects when the most common form of breast cancer has become resistant to treatment could double the average time it takes for the disease to progress, from around two-and-a-half to around six months, a new study shows.

Scientists have shown that a drug combination slows cancer cell growth in a type of non-small cell lung cancer when tested in the lab, offering potential for developing new treatments in the future.

The effect of combined hormone replacement therapy (HRT) in increasing a woman’s risk of breast cancer is likely to have been underestimated by a number of previous studies, according to a new prospective study published in the British Journal of Cancer.

If watching the stunning displays of athleticism in the Olympics inspired you to become more physically active, then why not consider becoming part of Team ICR? You could take part in one or more of our exciting sporting challenges — either here in the UK or around the world

Testing for the activity of two genes could pick out women who are at increased risk of dying from their breast cancers, suggests a new study of almost 2,000 patients.

Scientists have identified how an inherited genetic variant, associated with an increased risk of developing the most common type of leukaemia, helps cancer cells survive.

Combining radiotherapy with a virus that targets cancer cells kicks both treatments into overdrive to treat the deadliest form of skin cancer, a new study shows.

Genetic testing of patients with a rare form of cancer that can affect children and young adults can pick out genetic errors hidden in their family tree which increase the risk of a wide variety of cancer types.

Despite major breakthroughs in creating innovative cancer drugs, there is still an urgent need to explore more treatment options. Liz Burtally finds out how researchers are now looking outside the historical, well-trodden cancer pathways usually targeted by cancer therapeutics.